Abstract
Hyperhomocysteinemia is an independent risk factor for cardiovascular disease and is associated with primary causes of mortality and morbidity throughout the world. Several studies have been carried out to evaluate the effects of a diet inducing cystathionine-β-synthase, methyltetrafolate, folic acid, and vitamin B supplemented with methionine on the homocysteine metabolism and in lowering the plasma total homocysteine levels. A large number of molecular and biomedical studies in numerous animals, such as mice, rabbits, and pigs, have sought to elevate the plasma total homocysteine levels and to identify a disease model for human hyperhomocysteinemia. However, a specific animal model is not suitable for hyperhomocysteinemia in terms of all aspects of cardiovascular disease. In this review article, the experimental progress of animal models with plasma total homocysteine levels is examined to identify a feasible animal model of hyperhomocysteinemia for different aspects.
Similar content being viewed by others
Abbreviations
- HC:
-
Homocysteine
- CVD:
-
Cardiovascular disease
- ATP:
-
Adenosine triphosphate
- MTHFR:
-
Methylenetetrahydrofolate reductase
- CBS:
-
Cystathionine-β-synthase
- THF:
-
Tetrahydrofolate
- NO:
-
Nitric oxide
- O2 :
-
Oxygen
- SAM:
-
Sulfur adenosylmethionine
- SAH:
-
S-Adenosylhomocysteine
- MAT:
-
Methionine adenosyltransferase
- MT:
-
Methyltransferase
- MS:
-
Methionine synthase
References
Ables GP, Ouattara A, Hampton TG, Cooke D, Perodin F, Augie I, Orentreich DS (2015) Dietary methionine restriction in mice elicits an adaptive cardiovascular response to hyperhomocysteinemia. Sci Rep 5:8886. doi:10.1038/srep08886
Ambrosi P, Rolland PH, Bodard H, Barlatier A, Charpiot P, Guisgand G, Friggi A, Ghiringhelli O, Habib G, Bouvenot G, Garçon D, Luccioni R (1999) Effects of folate supplementation in hyperhomocysteinemic pigs. J Am Coll Cardiol 34(1):274–279
Buja LM, Kita T, Goldstein JL, Watanabe Y, Brown MS (1983) Cellular pathology of progressive atherosclerosis in the WHHL rabbit. An animal model of familial hypercholesterolemia. Arteriosclerosis 3(1):87–101
Catena C, Colussi G, Nait F, Capobianco F, Sechi LA (2014) Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients. Am J Hypertens 28(7):943–950. doi:10.1093/ajh/hpu248
Catena C, Colussi G, Url-Michitsch M, Nait F, Sechi LA (2015) Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension. J Am Soc Hypertens 9(3):167–175. doi:10.1016/j.jash.2014.12.020
Chang L, Geng B, Yu F, Zhao J, Jiang H, Du J, Tang C (2008) Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats. Amino Acids 34(4):573–585. doi:10.1007/s00726-007-0011-8
Chen Z, Karaplis AC, Ackerman SL, Pogribny IP, Melnyk S, Lussier-Cacan S, Chen MF, Pai AJ, Smith RS, Ohn SW, Bottiglieri T, Bagley P, Selhub J, Rudnicki MA, James SJ, Rozen R (2001) Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum Mol Genet 10:433–443
Clarke R, Lewington S, Lonn E, Armitage J, Manson JAE, Bønaa KH, Spence JD, Nygård O, Jamison R, Gaziano JM, Guarino P, Bennett D, Mir F, Peto R, Collins R (2010) Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med 170:1622–1631. doi:10.1001/archinternmed.2010.348
Clarke R, Bennett DA, Parish S, Verhoef P, Dotsch-Klerk M, Lathrop M, Xu P, Nordestgaard BG, Holm H, Hopewell JC, Saleheen D, Tanaka T, Anand SS, Chambers JC, Kleber ME, Ouwehand WH, Yamada Y, Elbers C, Peters B, Stewart AF, Reilly MM, Thorand B, Yusuf S, Engert JC, Assimes TL, Kooner J, Danesh J, Watkins H, Samani NJ, Collins R, Peto R, Group MSC (2012) Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias. PLoS Med 9(2):e1001177. doi:10.1371/journal.pmed.1001177
Cohen MV, Yang XM, Liu Y, Snell KS, Downey JM (1994) A new animal model of controlled coronary artery occlusion in conscious rabbits. Cardiovasc Res 28:61–65
Cottington EM (2002) Adverse event associated with methionine loading test: a case report. Arterioscler Thromb Vasc Biol 22(6):1046–1050. doi:10.1161/01.atv.0000020400.25088.a7
David S, Wald ML, Morris Joan K (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325:1202. doi:10.1136/bmj.325.7374.1202
Dayal S, Bottiglieri T, Arning E, Nobuyo M, Malinow MR, Sigmund CD, Heistad DD, Faraci FM, Lentz SR (2001) Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine β-synthase–deficient mice. Circ Res 88(11):1203–1209
Dayal S, Wilson KM, Leo L, Arning E, Bottiglieri T, Lentz SR (2006) Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia. Blood 108(7):2237–2243. doi:10.1182/blood-2006-02-005991
Devlin AM, Arning E, Bottiglieri T, Faraci FM, Rozen R, Lentz SR (2004) Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice. Blood 103:2624–2629. doi:10.1182/blood2003-09-3078
Elmore CL, Matthews RG (2007) The many flavors of hyperhomocyst(e)inemia: insights from transgenic and inhibitor-based mouse models of disrupted one-carbon metabolism. Antioxid Redox Signal 9(11):1911–1922. doi:10.1089/ars.2007.1795
Elnakish MT, Hassanain HH, Janssen PML (2012) Vascular Remodeling-associated hypertension leads to left ventricular hypertrophy and contractile dysfunction in profilin-1 transgenic mice. J Cardiovasc Pharmacol 60(6):544–552
Elshorbagy AK, Valdivia-Garcia M, Refsum H, Smith AD, Mattocks DA, Perrone CE (2010) Sulfur amino acids in methionine-restricted rats: hyperhomocysteinemia. Nutrition 26(11–12):1201–1204. doi:10.1016/j.nut.2009.09.017
Global status report on noncommunicable diseases (2014) Chapter 1 Global target 1: a 25% relative reduction in overall mortality from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases. http://www.who.int/nmh/publications/ncd-status-report-2014/en/. Accessed 7 July 2017
Glowacki R, Bald E, Jakubowski H (2010) Identification and origin of Nepsilon-homocysteinyl-lysine isopeptide in humans and mice. Amino Acids 39(5):1563–1569. doi:10.1007/s00726-010-0627-y
Gospe SMJ, Gietzen DW, Summers PJ, Lunetta JM, Miller JW, Selhub J, Ellis WG, Clifford AJ (1995) Behavioral and neurochemical changes in folate-deficient mice. Physiol Behav 58(5):935–941
Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, Ferran LJ Jr, Kohl B, Rao V, Kisiel W, Stern DM, Schmidt AM (2001) Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 107:675–683
Homocysteine Lowering Trialists’ Collaboration (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 316:894–898
Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288:2015–2022. doi:10.1001/jama.288.16.2015
Humphrey LL, Fu R, Rogers K, Freeman M, Helfand M (2008) Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin Proc 83(11):1203–1212. doi:10.4065/83.11.1203
Jones RWA, Jeremy JY, Koupparis A, Persad R, Shukla N (2005) Cavernosal dysfunction in a rabbit model of hyperhomocysteinaemia. BJU Int 95(1):125–130. doi:10.1111/j.1464-410X.2005.05263.x
Kakimoto T, Otsuka A, Kawaguchi H, Ogata K, Tanimoto A, Kanouchi H (2014) Plasma homocysteine concentrations in novel microminipigs. In Vivo 28:579–582
Kamat PK, Kyles P, Kalani A, Tyagi N (2016) Hydrogen sulfide ameliorates homocysteine-induced alzheimer’s disease-like pathology, blood-brain barrier disruption, and synaptic disorder. Mol Neurobiol 53(4):2451–2467. doi:10.1007/s12035-015-9212-4
Kang SS, Wong PWK, Malinow MR (1992) Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 12:279–298. doi:10.1146/annurev.nu.12.070192.001431
Katko M, Zavaczki E, Jeney V, Paragh G, Balla J, Varga Z (2012) Homocysteine metabolism in peripheral blood mononuclear cells: evidence for cystathionine beta-synthase activity in resting state. Amino Acids 43(1):317–326. doi:10.1007/s00726-011-1080-2
Kawaguchi H, Miyoshi N, Miura N, Fujiki M, Horiuchi M, Izumi Y, Miyajima H, Nagata R, Misumi K, Takeuchi T, Tanimoto A, Yoshida H (2011) Microminipig, a non-rodent experimental animal optimized for life science research: novel atherosclerosis model induced by high fat and cholesterol diet. J Pharmacol Sci 115(2):115–121. doi:10.1254/jphs.10R17FM
Klerk MVP, Clarke R, Blom HJ, Kok FJ et al (2002) MTHFR 677C->T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288:2023–2031
Lang D, Kredan MB, Moat SJ, Hussain SA, Powell CA, Bellamy MF, Powers HJ, Lewis MJ (2000) Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: role for superoxide anions. Arterioscler Thromb Vasc Biol 20:422–427
Lentz SR, Piegors DJ, Fernandez JA, Erger RA, Arning E, Malinow MR, Griffin JH, Bottiglieri T, Haynes WG, Heistad DD (2002) Effect of hyperhomocysteinemia on protein C activation and activity. Blood 100(6):2108–2112. doi:10.1182/blood-2002-03-0727
Leong XF, Ng CY, Jaarin K (2015) Animal models in cardiovascular research: hypertension and atherosclerosis. Biomed Res Int 2015:528–757. doi:10.1155/2015/528757
Li Y, Huang T, Zheng Y, Muka T, Troup J, Hu FB (2016) Folic acid supplementation and the risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. J Am Heart Assoc. doi:10.1161/JAHA.116.003768
Liao J, Huang W, Liu G (2017) Animal models of coronary heart disease. J Biomed Res 31(1):3–10. doi:10.7555/JBR.30.20150051
Liu G, Chen S, Zhong J, Teng K, Yin Y (2017) Crosstalk between tryptophan metabolism and cardiovascular disease, mechanisms, and therapeutic implications. Oxid Med Cell Longev 2017:1602074. doi:10.1155/2017/1602074
Marcus J, Menon V (2007) Homocysteine lowering and cardiovascular disease risk: lost in translation. Can J Cardiol 23(9):707–710. doi:10.1016/S0828-282X(07)70814-0
Miyoshi N, Horiuchi M, Inokuchi Y, Miyamoto Y, Miura N, Tokunaga S, Fujiki M, Izumi Y, Miyajima H, Nagata R, Misumi K, Takeuchi T, Tanimoto A, Yasuda N, Yoshida H, Kawaguchi H (2010) Novel microminipig model of atherosclerosis by high fat and high cholesterol diet, established in Japan. In Vivo 24:671–680
Nandi SS, Mishra PK (2017) H2S and homocysteine control a novel feedback regulation of cystathionine beta synthase and cystathionine gamma lyase in cardiomyocytes. Sci Rep 7(1):3639. doi:10.1038/s41598-017-03776-9
Recchia FA, Lionetti V (2007) Animal models of dilated cardiomyopathy for translational research. Vet Res Commun 31(Suppl 1):35–41. doi:10.1007/s11259-007-0005-8
Robert K, Nehmé J, Bourdon E, Pivert G, Friguet B, Delcayre C, Delabar JM, Janel N (2005) Cystathionine β synthase deficiency promotes oxidative stress, fibrosis, and steatosis in mice liver. Gastroenterology 128(5):1405–1415. doi:10.1053/j.gastro.2005.02.034
Schwahn BC, Laryea MD, Chen Z, Melnyk S, Pogribny I, Garrow T, James SJ, Rozen R (2004) Betaine rescue of an animal model with methylenetetrahydrofolate reductase deficiency. Biochem J 382:831–840
Selhub J (1999) Homocysteine metabolism. Annu Rev Nutr 19:217–246. doi:10.1146/annurev.nutr.19.1.217
Sipahioglu MH, Saglam E, Oymak O, Sav T, Tokgoz B, Karaca H, Utas C (2005) Effect of cyclosporine A on total homocysteine level in a rabbit model. Transpl Proc 37(5):2371–2374. doi:10.1016/j.transproceed.2005.03.053
Tan H, Jiang X, Yang F, Li Z, Liao D, Trial J, Magera MJ, Durante W, Yang X, Wang H (2006) Hyperhomocysteinemia inhibits post-injury reendothelialization in mice. Cardiovasc Res 69(1):253–262. doi:10.1016/j.cardiores.2005.08.016
Tsang HG, Rashdan NA, Whitelaw CBA, Corcoran BM, Summers KM, MacRae VE (2016) Large animal models of cardiovascular disease. Cell Biochem Funct 34:113–132. doi:10.1002/cbf.3173
Virdis A, Iglarz M, Neves MF, Amiri F, Touyz RM, Rozen R, Schiffrin EL (2003) Effect of hyperhomocysteinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice. Arterioscler Thromb Vasc Biol 23(8):1352–1357. doi:10.1161/01.ATV.0000083297.47245.DA
Wang L, Jhee KH, Hua X, DiBello PM, Jacobsen DW, Kruger WD (2004) Modulation of cystathionine beta-synthase level regulates total serum homocysteine in mice. Circ Res 94(10):1318–1324. doi:10.1161/01.RES.0000129182.46440.4a
Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Malinow MR, Maeda N (1995) Mice deficient in cystathionine β-synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci USA 92:1585–1589
Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, Zhou J, Maeda N, Krisans SK, Malinow MR, Austin RC (2001) Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 107:1263–1273
Wierzbicki AS (2016) Homocysteine and cardiovascular disease: a review of the evidence. Diab Vasc Dis Res 4(2):143–149. doi:10.3132/dvdr.2007.033
Zhang S, Bai YY, Luo LM, Xiao WK, Wu HM, Ye P (2014) Association between serum homocysteine and arterial stiffness in elderly: a community-based study. J Geriatr Cardiol 11(1):32–38. doi:10.3969/j.issn.1671-5411.2014.01.007
Zhou Ji, Møller Jan, Danielsen Carl C, Bentzon Jacob, Ravn Hanne B, Austin Richard C, Falk E (2001) Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 21:1470–1476
Zidan RA, Elnegris HM (2015) Effect of homocysteine on the histological structure of femur in young male albino rats and the possible protective role of folic acid. J Histol Histopathol 2(1):16. doi:10.7243/2055-091x-2-16
Acknowledgements
This research was supported by National Natural Science Foundation of China (No. 31772642, 31672457, 31702125, 41771300), National Key Research and Development Program of China (2016YFD0500504), International Partnership Program of Chinese Academy of Sciences (161343KYSB20160008), and the Ministry of Science and Technology of the People’s Republic of China (2014BAD14B01).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that there is no potential conflict of interest regarding the publication of this article.
Ethical statements
This review article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Handling Editor: J. D. Wade.
Rights and permissions
About this article
Cite this article
Azad, M.A.K., Huang, P., Liu, G. et al. Hyperhomocysteinemia and cardiovascular disease in animal model. Amino Acids 50, 3–9 (2018). https://doi.org/10.1007/s00726-017-2503-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-017-2503-5